Arun Arunachalam

Employment

• Sanofi Senior Director - Global
  2018 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits
  Vaccines 2024 DOI: 10.3390/vaccines12040396
  +Save
• Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine
  Vaccine 2023 DOI: 10.1016/j.vaccine.2023.06.051
  +Save
• Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies
  Frontiers in Immunology 2023 DOI: 10.3389/fimmu.2023.1128683
  +Save
• Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®
  Glycoconjugate Journal 2022 DOI: 10.1007/s10719-022-10050-2
  +Save
• A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines.
  Frontiers in immunology 2022 DOI: 10.3389/fimmu.2022.814088
  +Save
• Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
  npj Vaccines 2021 DOI: https://doi.org/10.1038/s41541-021-00403-7
  +Save
• Comparability of biotherapeutics: characterization of protein vaccine antigens
  Pharmaceutical Bioprocessing 2013 DOI: 10.4155/PBP.13.42
  +Save
• Defective antigen processing in GILT-free mice.
  Science (New York, N.Y.) 2001 DOI: 10.1126/science.1065500
  +Save
• Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT).
  Proceedings of the National Academy of Sciences of the United States of America 2000 DOI: 10.1073/pnas.97.2.745
  +Save
• Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action.
  The Journal of biological chemistry 2000 DOI: 10.1074/jbc.m003459200
  +Save